Tirzepatide (TR30 / 30mg) Research Grade Peptide Vial

≥99.2%

-20°C Stored

Lyophilized cake under nitrogen flush. Individual batch verification report and HPLC chromatogram provided with each shipment.

Metabolic & Incretin ResearchCAS: 2023788-19-2

Tirzepatide (TR30 / 30mg)

Institutional synthesis standard for receptor binding assays.

Purity≥99.2%

Format30mg Lyophilized Vial

FormulaDetermined

Mol. WeightDetermined

Request Formal Quotation (RFQ)WhatsApp RFQ

Verified Analytical DossiersAvailable for Inspection

Laboratory Research Disclaimer: This chemical compound is sold strictly for analytical, in vitro, and laboratory research investigations. Not approved for human or veterinary administration.

Full Technical Specifications

Technical Specification Matrix

Shenghua Lab Reference

Product Name

Tirzepatide (TR30 / 30mg)

CAS Number

2023788-19-2

Amino Acid Sequence

Proprietary / Client Specified

Molecular Formula

Determined per batch

Molecular Weight

Determined per batch

Assayed Purity

≥99.2%

Physical Format

30mg Lyophilized Vial

Cat. No	Configuration / Name	Packaging Spec	Purity / QC	Stock Status
TR5	Tirzepatide 5mg (TR5)	5mg*10vials	≥99.0% (HPLC)	In Stock (-20°C)
TR10	Tirzepatide 10mg (TR10)	10mg*10vials	≥99.0% (HPLC)	In Stock (-20°C)
TR15	Tirzepatide 15mg (TR15)	15mg*10vials	≥99.0% (HPLC)	In Stock (-20°C)
TR20	Tirzepatide 20mg (TR20)	20mg*10vials	≥99.0% (HPLC)	In Stock (-20°C)
TR30	Tirzepatide 30mg (TR30)	30mg*10vials	≥99.0% (HPLC)	In Stock (-20°C)

Tirzepatide (TR30 / 30mg)

Full Technical Specifications

Technical Specification Matrix

Tirzepatide Series Product Matrix

Related Metabolic & Incretin Research Standards

Tirzepatide (TR5 / 5mg)

Tirzepatide (TR10 / 10mg)

Tirzepatide (TR15 / 15mg)